Big Statement By Aurobindo As It Seals $1bn Sandoz US Deal

 
• By Anju Ghangurde

Aurobindo is betting big, buying certain portions of Sandoz’s US portfolio in a deal potentially worth $1bn. The acquisition positions the Indian firm in the top league in the overall US generics space by Rx and also segments like dermatology, but much could depend on how effectively Aurobindo delivers on value creation potential amid ongoing price pressures.

Big money
AUROBINDO HAS SEALED THE LARGEST OUTBOUND M&A DEAL BY AN INDIAN PHARMA FIRM • Source: Shutterstock

More from Business

More from Scrip